NECTAR

The Nectar project falls right in the Plasma Medicine field, an interdisciplinary field among physics, chemistry, engineering, and life sciences that emerged in the last two decades as an innovative area of research. The final aim of the Plasma Medicine is to use cold atmospheric plasmas (CAP) in the clinical practice. CAP has been reported to selectively kill cancer cells without damaging the surrounding normal tissues and the present project proposes to study indirect CAP treatment of clinical solutions - Plasma Treated Water Solutions (PTWS) - enriched with biomolecules that have an ambitious bifunctional effect: efficacy against head and neck squamous carcinoma (HNSCC) cells and oral pathogenic bacteria without altering the normal functionalities of healthy cells.